Diversify Wealth Management LLC bought a new position in Colgate-Palmolive (NYSE:CL – Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 7,527 shares of the company’s stock, valued at approximately $650,000.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. Peak Financial Advisors LLC acquired a new position in Colgate-Palmolive in the fourth quarter valued at about $1,315,000. Gordian Advisors LLC acquired a new position in shares of Colgate-Palmolive in the 3rd quarter valued at approximately $602,000. Carrera Capital Advisors increased its stake in Colgate-Palmolive by 23.1% during the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after purchasing an additional 7,353 shares in the last quarter. Fiduciary Alliance LLC acquired a new stake in Colgate-Palmolive during the 4th quarter worth approximately $4,066,000. Finally, Vontobel Holding Ltd. lifted its stake in Colgate-Palmolive by 224.6% in the third quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company’s stock valued at $82,626,000 after buying an additional 550,750 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.
Insider Buying and Selling at Colgate-Palmolive
In related news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.37% of the company’s stock.
Analyst Ratings Changes
Get Our Latest Research Report on CL
Colgate-Palmolive Stock Performance
Shares of NYSE CL opened at $88.27 on Wednesday. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The company has a market capitalization of $72.12 billion, a P/E ratio of 25.29, a P/E/G ratio of 3.62 and a beta of 0.44. Colgate-Palmolive has a 12 month low of $79.69 and a 12 month high of $109.30. The stock has a 50 day moving average of $92.13 and a 200-day moving average of $97.71.
Colgate-Palmolive Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.27%. Colgate-Palmolive’s dividend payout ratio (DPR) is 57.31%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- About the Markup Calculator
- SAP’s Strong Momentum: A Bullish Setup for Investors
- Basic Materials Stocks Investing
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- Retail Stocks Investing, Explained
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.